O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study - Archive ouverte HAL Access content directly
Conference Papers Year : 2015

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

D. Botta-Fridlund
  • Function : Author
A. Coilly
  • Function : Author
V. Leroy
  • Function : Author
H. Danjou
  • Function : Author
S. Radenne
  • Function : Author
Franck Durand
  • Function : Author
V. Di Martino
  • Function : Author
V. De Ledinghen
  • Function : Author
P. Houssel-Debry
  • Function : Author
L D’alteroche
  • Function : Author
C. Duvoux
  • Function : Author
F. Conti
  • Function : Author
V. Canva
  • Function : Author
A. Diallo
  • Function : Author
A. Rohel
  • Function : Author
J. -C. Duclos-Vallée
  • Function : Author
G. -P Pageaux
  • Function : Author

Abstract

no abstract
Not file

Dates and versions

hal-01162706 , version 1 (11-06-2015)

Identifiers

Cite

J. Dumortier, D. Botta-Fridlund, A. Coilly, V. Leroy, C. Fougerou-Leurent, et al.. O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S247--S248, ⟨10.1016/S0168-8278(15)30128-8⟩. ⟨hal-01162706⟩
56 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More